Background Coronavirus disease 2019 (COVID-19) is associated with systemic inflammation, which may dysregulate platelet function. Total Thrombus-Formation Analysis System (T-TAS) is a flow-chamber device that analyses platelet-mediated thrombus formation in capillary channels through the following parameters: (1) the area under the flow-pressure curve (AUC), (2) occlusion start time (OST), time needed to reach OST, and (3) occlusion time (OT), time needed to reach the occlusion pressure. Methods and Findings Sixty-one COVID-19 patients admitted to intensive, subintensive, and low intensive care were prospectively enrolled according to the time of admission: group A (up to 8 days) ( n =18); group B (from 9 to 21 days) ( n =19), and group C (>21 days) ( n =24). T-TAS measurements were performed at enrolment and after 7 days. Median OST was similar among groups. AUC was lower in group A compared to B ( p =0.001) and C ( p =0.033). OT was longer in group A compared to B ( p =0.001) and C ( p =0.028). Platelet count (PC) was higher in group B compared to A ( p =0.024). The linear regression showed that OT and AUC were independent from PC in group A (OT: 0.149 [95% confidence interval [CI]: -0.326 to 0.624], p =0.513 and AUC: 0.005 [95% CI: -0.008 to 0.017], p =0,447). In contrast, in group B, PC was associated with OT (-0.019 [-0.028 to 0.008], p =0.023) and AUC (0.749 [0.358-1.139], p =0,015), similarly to group C. Conversely, patients with different illness severity had similar T-TAS parameters. Conclusion COVID-19 patients display an impaired platelet thrombus formation in the early phase of the disease compared to later stages and controls, independently from illness severity.

Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study / S. Ghirardello, A. Lecchi, A. Artoni, M. Panigada, S. Aliberti, E. Scalambrino, S. La Marca, M. Boscarino, A. Gramegna, P. Properzi, C. Abruzzese, F. Blasi, G. Grasselli, F. Mosca, A. Tripodi, F. Peyvandi. - In: THROMBOSIS AND HAEMOSTASIS. - ISSN 0340-6245. - (2021). [Epub ahead of print] [10.1055/s-0041-1722919]

Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study

Artoni, Andrea;Aliberti, Stefano;Scalambrino, Erica;La Marca, Silvia;Gramegna, Andrea;Properzi, Paolo;Blasi, Francesco;Grasselli, Giacomo;Mosca, Fabio;Tripodi, Armando;Peyvandi, Flora
2021

Abstract

Background Coronavirus disease 2019 (COVID-19) is associated with systemic inflammation, which may dysregulate platelet function. Total Thrombus-Formation Analysis System (T-TAS) is a flow-chamber device that analyses platelet-mediated thrombus formation in capillary channels through the following parameters: (1) the area under the flow-pressure curve (AUC), (2) occlusion start time (OST), time needed to reach OST, and (3) occlusion time (OT), time needed to reach the occlusion pressure. Methods and Findings Sixty-one COVID-19 patients admitted to intensive, subintensive, and low intensive care were prospectively enrolled according to the time of admission: group A (up to 8 days) ( n =18); group B (from 9 to 21 days) ( n =19), and group C (>21 days) ( n =24). T-TAS measurements were performed at enrolment and after 7 days. Median OST was similar among groups. AUC was lower in group A compared to B ( p =0.001) and C ( p =0.033). OT was longer in group A compared to B ( p =0.001) and C ( p =0.028). Platelet count (PC) was higher in group B compared to A ( p =0.024). The linear regression showed that OT and AUC were independent from PC in group A (OT: 0.149 [95% confidence interval [CI]: -0.326 to 0.624], p =0.513 and AUC: 0.005 [95% CI: -0.008 to 0.017], p =0,447). In contrast, in group B, PC was associated with OT (-0.019 [-0.028 to 0.008], p =0.023) and AUC (0.749 [0.358-1.139], p =0,015), similarly to group C. Conversely, patients with different illness severity had similar T-TAS parameters. Conclusion COVID-19 patients display an impaired platelet thrombus formation in the early phase of the disease compared to later stages and controls, independently from illness severity.
platelets; platelet function; antiplatelet therapy; arterial thrombosis; blood coagulation; T-TAS; venous thromboembolism
Settore MED/10 - Malattie dell'Apparato Respiratorio
Settore MED/09 - Medicina Interna
5-feb-2021
THROMBOSIS AND HAEMOSTASIS
Article (author)
File in questo prodotto:
File Dimensione Formato  
s-0041-1722919.pdf

non disponibili

Tipologia: Publisher's version/PDF
Dimensione 1.13 MB
Formato Adobe PDF
1.13 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/814134
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact